Division of Neonatology, Department of Pediatrics, SBU Ankara Dr. Sami Ulus Maternity Child Health and Diseases Training and Research Hospital, Ankara, Turkey.
Department of Neonatology, Ankara City Hospital, Cankaya, Ankara, Turkey.
Am J Perinatol. 2022 Dec;39(16):1820-1827. doi: 10.1055/s-0041-1727156. Epub 2021 Apr 14.
This study aimed to ascertain the effects of astaxanthin (ASX) in an experimental necrotizing enterocolitis (NEC) model using rat pups.
Forty-two pups born from five Wistar albino rats were randomly divided into three groups as the control group, NEC + placebo (saline), and NEC + ASX. Pups in the NEC + ASX group were given 100 mg/kg/day oral ASX from day 1 to day 4 of the study. Saline of 2 mL/kg was given to the NEC + placebo group. Histopathological, immunohistochemical (caspase-3), and biochemical evaluations including the total antioxidant status (TAS), total oxidant status (TOS), superoxide dismutase (SOD), glutathione (GSH), lipid hydroperoxide (LPO), 8-hydroxydeoxyguanosine (8-OHdG), advanced oxidation protein products (AOPP), myeloperoxidase (MPO), tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and nuclear factor erythroid 2-related factor 2 (Nfr-2) activities were all performed.
A better survival rate and weight gain were demonstrated in the NEC + ASX group ( < 0.05). In the histopathological evaluation, the severity of intestinal damage was significantly reduced in the NEC + ASX group, as well as decreased apoptosis (enzyme-linked immunosorbent assay [ELISA] for caspase-3; = 0.001). The biochemical analyses of intestinal tissue TOS, oxidative stress index (OSI; TOS/TAS), IL-1β, LPO, 8-OHdG, AOPP, caspase-3 ( < 0.001 for all), and TNF-α and MPO ( = 0.001 for both parameters) levels were lower in the NEC + ASX group than in the NEC + placebo group. Nrf-2, TAS, GSH, and SOD levels were higher in the NEC + ASX group than in the NEC + placebo group ( = 0.001, 0.001, <0.001, and 0.01, respectively).
ASX treatment has been shown to effectively reduce the severity of intestinal damage in NEC due to its antioxidant, anti-inflammatory, and antiapoptotic properties.
· NEC causes extremely high morbidity and mortality, as well as many complications.. · We investigated the effectiveness of ASX in the experimental NEC model created in rat pups.. · First study examining the effect of ASX on the experimental NEC rat model..
本研究旨在使用大鼠幼仔的实验性坏死性小肠结肠炎 (NEC) 模型来确定虾青素 (ASX) 的作用。
42 只来自 5 只 Wistar 白化大鼠的幼仔被随机分为三组:对照组、NEC + 安慰剂(生理盐水)和 NEC + ASX。NEC + ASX 组从研究的第 1 天到第 4 天每天给予 100mg/kg 口服 ASX。NEC + 安慰剂组给予 2mL/kg 生理盐水。进行组织病理学、免疫组织化学(半胱天冬酶-3)和生化评估,包括总抗氧化状态 (TAS)、总氧化状态 (TOS)、超氧化物歧化酶 (SOD)、谷胱甘肽 (GSH)、脂质过氧化物 (LPO)、8-羟基脱氧鸟苷 (8-OHdG)、高级氧化蛋白产物 (AOPP)、髓过氧化物酶 (MPO)、肿瘤坏死因子-α (TNF-α)、白细胞介素-1β (IL-1β) 和核因子红细胞 2 相关因子 2 (Nfr-2) 活性。
NEC + ASX 组的生存率和体重增加均更高( < 0.05)。在组织病理学评估中,NEC + ASX 组的肠道损伤严重程度明显减轻,细胞凋亡减少(酶联免疫吸附试验 [ELISA] 检测 caspase-3; = 0.001)。NEC + ASX 组的肠道组织 TOS、氧化应激指数 (OSI;TOS/TAS)、IL-1β、LPO、8-OHdG、AOPP、caspase-3(所有参数均为 < 0.001)和 TNF-α 和 MPO(均为 = 0.001)水平均低于 NEC + 安慰剂组。NEC + ASX 组的 Nrf-2、TAS、GSH 和 SOD 水平高于 NEC + 安慰剂组(均为 = 0.001、0.001、<0.001 和 0.01)。
ASX 治疗可有效减轻 NEC 引起的肠道损伤的严重程度,这归因于其抗氧化、抗炎和抗凋亡特性。
· NEC 导致极高的发病率和死亡率,以及许多并发症。· 我们研究了 ASX 在大鼠幼仔实验性 NEC 模型中的有效性。· 首次研究 ASX 对实验性 NEC 大鼠模型的影响。